Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M. Sadanaga A, et al. Among authors: igawa t. Arthritis Rheum. 2005 Dec;52(12):3987-96. doi: 10.1002/art.21424. Arthritis Rheum. 2005. PMID: 16320345 Free article.
Association between IFNA genotype and the risk of systemic lupus erythematosus.
Nakashima H, Matsuno S, Akahoshi M, Miyake K, Inoue Y, Tanaka Y, Ninomiya I, Shimizu S, Igawa T, Sadanaga A, Otsuka T, Harada M. Nakashima H, et al. Among authors: igawa t. Clin Rheumatol. 2005 Feb;24(1):38-40. doi: 10.1007/s10067-004-0966-8. Epub 2004 Jul 20. Clin Rheumatol. 2005. PMID: 15674657
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M. Sadanaga A, et al. Among authors: igawa t. Arthritis Rheum. 2007 May;56(5):1618-28. doi: 10.1002/art.22571. Arthritis Rheum. 2007. PMID: 17469144 Free article.
Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Sumiyoshi R, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A. Ichinose K, et al. Among authors: igawa t. Arthritis Res Ther. 2020 Jul 22;22(1):175. doi: 10.1186/s13075-020-02271-3. Arthritis Res Ther. 2020. PMID: 32698892 Free PMC article.
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis.
Umeda M, Karino K, Satyam A, Yoshida N, Hisada R, Bhargava R, Vichos T, Kunzler AL, Igawa T, Ichinose K, Torigoe K, Nishino T, Maeda T, Owen CA, Abdi R, Kawakami A, Tsokos GC. Umeda M, et al. Among authors: igawa t. Arthritis Rheumatol. 2024 Sep 15. doi: 10.1002/art.42987. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39279154
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.
Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A. Ichinose K, et al. Among authors: igawa t. Clin Immunol. 2018 Dec;197:161-168. doi: 10.1016/j.clim.2018.10.002. Epub 2018 Oct 5. Clin Immunol. 2018. PMID: 30296591
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis.
Iwamoto N, Sato S, Kurushima S, Michitsuji T, Nishihata S, Okamoto M, Tsuji Y, Endo Y, Shimizu T, Sumiyoshi R, Suzuki T, Okada A, Koga T, Kawashiri SY, Fujikawa K, Igawa T, Aramaki T, Ichinose K, Tamai M, Nakamura H, Mizokami A, Origuchi T, Ueki Y, Eguchi K, Kawakami A. Iwamoto N, et al. Among authors: igawa t. Arthritis Res Ther. 2021 Jul 23;23(1):197. doi: 10.1186/s13075-021-02582-z. Arthritis Res Ther. 2021. PMID: 34301311 Free PMC article.
434 results